SEAGEN INC's ticker is SGEN and the CUSIP is 81181C104. A total of 607 filers reported holding SEAGEN INC in Q3 2023. The put-call ratio across all filers is 3.99 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,757 | +25.7% | 17,711 | +14.0% | 0.03% | +35.0% |
| Q2 2023 | $2,989 | -5.3% | 15,530 | -0.4% | 0.02% | -9.1% |
| Q1 2023 | $3,156 | +59.9% | 15,586 | +1.5% | 0.02% | +46.7% |
| Q4 2022 | $1,974 | -99.9% | 15,359 | +1.2% | 0.02% | -11.8% |
| Q3 2022 | $2,076,000 | -17.6% | 15,171 | +6.6% | 0.02% | -10.5% |
| Q2 2022 | $2,518,000 | +29.0% | 14,229 | +5.0% | 0.02% | +58.3% |
| Q1 2022 | $1,952,000 | +2.3% | 13,550 | +9.8% | 0.01% | +9.1% |
| Q4 2021 | $1,909,000 | -2.4% | 12,345 | +7.2% | 0.01% | -15.4% |
| Q3 2021 | $1,955,000 | +20.4% | 11,515 | +12.0% | 0.01% | +18.2% |
| Q2 2021 | $1,624,000 | +22.8% | 10,284 | +8.0% | 0.01% | +10.0% |
| Q1 2021 | $1,322,000 | -9.8% | 9,521 | +13.8% | 0.01% | -9.1% |
| Q4 2020 | $1,465,000 | – | 8,366 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 46,912,266 | $6,419,005,000 | 42.04% |
| Ally Bridge Group (NY) LLC | 92,506 | $12,658,000 | 8.36% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 166,200 | $22,739,000 | 7.29% |
| Eagle Health Investments LP | 174,902 | $23,932,000 | 5.49% |
| Avoro Capital Advisors LLC | 1,865,000 | $255,188,000 | 4.71% |
| Lagoda Investment Management, L.P. | 47,955 | $6,562,000 | 4.67% |
| Nan Fung Group Holdings Ltd | 47,096 | $6,444,000 | 4.11% |
| Ikarian Capital, LLC | 150,000 | $20,525,000 | 4.09% |
| Antara Capital LP | 946,100 | $129,455,000 | 3.42% |
| SECTOR GAMMA AS | 84,730 | $11,594,000 | 2.99% |